Key result
American ginseng compounds improve verapamil-induced heart failure metrics in a zebrafish model.
Why the study?
Does American ginseng extract and its specific components improve heart failure phenotypes in a verapamil-induced zebrafish model?
Does American ginseng extract and its specific components improve heart failure phenotypes in a verapamil-induced zebrafish model?
Specific components of American ginseng, including ginsenosides and organic acids, demonstrate anti-heart failure activity in a zebrafish model, providing potential pharmacodynamic markers for quality control.
Answers are grounded in this paper and cite their sources.
These components should not yet change practice; leaves open their utility as pharmacodynamic markers pending mammalian validation.
We have rapidly identified the P-markers against heart failure in AG using the zebrafish model and metabolomics technology. These P-markers may provide new reference standards for quality control and new drug development of AG.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2022) studied Heart failure. American ginseng extract and active components (ginsenosides Rg3, Rg5, Rg6, malic acid, quinic acid, pseudoginsenoside F11) vs. Verapamil hydrochloride (200 μM) model group was evaluated on Improvement in heart failure metrics (pericardial area, venous congestion area, and SV-BA distance) (p=<0.05). Ginsenoside Rg3, Rg5, Rg6, malic acid, quinic acid, and pseudoginsenoside F11 from American ginseng significantly improved verapamil-induced heart failure in a zebrafish model.
Synapse has enriched 10 related papers. Consider them for comparative context: